Monica Bhatia, MD

Open
Call
Website

Advertisement

Photos

161 Fort Washington Ave
New York, NY 10032
Monica Bhatia, MD specializes in the care of children with noncancerous blood disorders who may benefit from bone marrow transplantation, especially sickle cell anemia. She and her colleagues are working to reduce the toxicity (side effects) and complications of this treatment without compromising its effectiveness, and to make it available to more patients. The field of pediatric hematology brings with it many intellectual challenges, and bone marrow transplantation in particular is especially dynamic. Dr. Bhatia has the opportunity to provide care for the sickest children, potentially curing their disease. She builds strong relationships with her patients and their families that last for years. It is inspiring for her to see young patients grow up to lead healthy, productive lives. NewYork-Presbyterian/Morgan Stanley Children's Hospital has a robust program for bone marrow transplantation for sickle cell anemia - the only cure for this disease. Dr. Bhatia and her team have witnessed remarkable results among children who are cured with bone marrow transplantation and spared from the potentially life-threatening complications of sickle cell disease. Yet despite the advances made, only 15 percent of patients with sickle cell disease have a matched sibling bone marrow donor. Therefore, Dr. Bhatia and her team conduct research to evaluate a procedure called "CD34-selected stem cell transplantation" to remove T-cells from donor bone marrow for patients without a matched sibling donor. This approach reduces the risk of graft-versus-host disease (GVHD), a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach to harnessing stem cells could potentially make bone marrow transplantation a safer, effective option for many patients who are seeking a cure for sickle cell disease. Dr. Bhatia and her colleagues are currently assessing reduced-intensity transplantation, which uses lower doses of chemotherapy to decrease the risk of side effects and long-term complications without lowering the effectiveness of treatment. She is also interested in looking for ways to further improve the quality of life of patients who have had a bone marrow transplant in addition to fertility preservation.
Click or call for more information
Owner verified
See a problem?

You might also like

Thomas A. Imahiyerobo, MD
Internal medicine practitioners

Thomas A. Imahiyerobo, MD

A native of Boston, Massachusetts, Dr. Imahiyerobo received his B.A. from Harvard University where he graduated with Honors, cum laude. After also receiving his M.D. from Harvard Medical School, Dr. Imahiyerobo entered the combined Plastic Surgery Residency at New York Presbyterian/Columbia and New York Presbyterian/ Weill Cornell. During his residency, Dr. Imahiyerobo was the recipient of numerous honors and awards, including the Dicran Goulian award for academic excellence in Plastic Surgery, as well as the Weill Cornell Alumni Council award for Distinguished House Staff. During his final year of residency Dr. Imahiyerobo served as chief resident in Plastic Surgery and was recognized by New York Presbyterian Hospital for his outstanding patient care. Dr. Imahiyerobo’s areas of expertise include the treatment of cleft lip, cleft palate, craniosynostosis, frontal facial advancement and orthognathic (jaw) surgery. He also specializes in the care of adult cosmetic and reconstructive surgery of the head and neck. He helps lead the Craniofacial Center at Morgan Stanley Children’s Hospital, where he is committed to providing comprehensive, cutting-edge, compassionate care to patients of all ages with craniofacial differences. He has completed additional training in Craniofacial and Pediatric Plastic Surgery during his fellowship at the Children’s Hospital of Los Angeles. While there, he was an integral part of one of the largest cleft and craniofacial teams in the country. Dr. Imahiyerobo is the author of numerous academic publications. He has been a speaker at national meetings of the American Society of Plastic Surgeons, The American Society of Aesthetic Plastic Surgery and the Plastic Surgery Research Council. In 2014 he was awarded the prestigious Gaspar Anastasi Award for best presentation during the Resident and Fellows Forum at the meeting of the American Society of Aesthetic Plastic Surgery. His current research interest includes the use of innovative approaches to treat global midface hypoplasia and severe Class III malocclusion. He is also focused on outcomes research for cleft lip and palate surgery, as well as the effects of craniosynostosis on pediatric cognitive development. Give to the Cleft and Craniofacial Fund »Read how Dr. Imahiyerobo helped Lily, a child with craniosynostosis »
Howard J Worman, MD
Internal medicine practitioners

Howard J Worman, MD

Howard J. Worman, M.D. is Professor of Medicine and Pathology and Cell Biology at Columbia University’s College of Physicians and Surgeons. Dr. Worman received his BA from Cornell University and MD from the University of Chicago Pritzker School of Medicine. He did clinical training in internal medicine at New York Hospital-Cornell Medical Center and postdoctoral research training in cell biology at Rockefeller University. He then obtained clinical training in liver diseases at the Mount Sinai Medical Center. Dr. Worman is internationally recognized for his research in cell biology and hepatology. His laboratory research is focused on primarily on the cell biology of rare genetic diseases. These include different types of muscular dystrophy, cardiomyopathy, lipodystrophy and premature aging syndromes (progeria) . He also does research on non-alcoholic fatty liver disease and on the characterization of antibodies in autoimmune liver diseases. His clinical practice is primarily devoted to consultation in liver diseases. Dr. Worman is an author on over 200 scientific publications. In 1998, he was elected to membership in the American Society for Clinical Investigator and, in 2010, to the Association of American Physicians. He has served on the Editorial Boards of Hepatology, Gastroenterology, Molecular Biology of the Cell and Journal of Autoimmunity and as a Section Editor of BMC Cell Biology. Dr. Worman is also author of the popular Liver Disorders and Hepatitis Sourcebook (McGraw-Hill, 2006). Email: hjw14@cumc.columbia.edu
United StatesNew YorkNew YorkMonica Bhatia, MD

Partial Data by Infogroup (c) 2025. All rights reserved.

Yext

Partial Data by Foursquare.

Advertisement